Both groups exhibited insignificant differences in age, sex, race, comorbidities, medications, and most lab results
More participants in the semaglutide group than in the placebo group achieved weight reductions of 5% or more (86% of participants vs 32%), 10% or more (69% vs 12%) and 15% or more (51% vs 5%) at week 68
Its especially suited for individuals looking for high-quality skincare with proven results
Finally, reach out to your healthcare team for guidance on replacing the expired medication and adjusting your treatment plan
Good candidates include adults with: A body mass index (BMI) of 30 kg/m or higher (classified as obesity), or A BMI of 27 kg/m or higher (overweight) who also have at least one weight-related health condition, such as: Hypertension (high blood pressure) Type 2 diabetes Dyslipidemia (abnormal cholesterol) Obstructive sleep apnea Comprehensive Evaluation Process Before starting tirzepatide, our providers will conduct a thorough assessment of your overall health, medical history, and current medications